adherence apps

Proposed framework lessens FDA's regulatory requirements for prescription drug companion apps
By Dave Muoio | 12:19 pm | November 19, 2018
The agency's proposal would classify the majority of software released by pharmas as "promotional labeling" that would not require premarket review.